It was suggested that both CCR2 and CCR5 expression were increased in AD patients compared to controls; but two studies from Italy (28, 31) and two studies from Spain (29, 30) showed no statistically significant differences between AD and control groups. Here, CCR5 is linked to Alzheimer disease.